3L0T

Crystal structure of catalytic domain of TACE with hydantoin inhibitor

Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.92 Å
  • R-Value Free: 0.239 
  • R-Value Work: 0.212 

wwPDB Validation 3D Report Full Report


This is version 1.2 of the entry. See complete history. 

Literature

Discovery and SAR of hydantoin TACE inhibitors.

Yu, W., Guo, Z., Orth, P., Madison, V., Chen, L., Dai, C., Feltz, R.J., Girijavallabhan, V.M., Kim, S.H., Kozlowski, J.A., Lavey, B.J., Li, D., Lundell, D., Niu, X., Piwinski, J.J., Popovici-Muller, J., Rizvi, R., Rosner, K.E., Shankar, B.B., Shih, N.Y., Siddiqui, M.A., Sun, J., Tong, L., Umland, S., Wong, M.K., Yang, D.Y., Zhou, G.

(2010) Bioorg.Med.Chem.Lett. 20: 1877-1880

  • DOI: 10.1016/j.bmcl.2010.01.148
  • Primary Citation of Related Structures:  

  • PubMed Abstract: 

    • We disclose inhibitors of TNF-alpha converting enzyme (TACE) designed around a hydantoin zinc binding moiety. Crystal structures of inhibitors bound to TACE revealed monodentate coordination of the hydantoin to the zinc. SAR, X-ray, and modeling desi ...

    We disclose inhibitors of TNF-alpha converting enzyme (TACE) designed around a hydantoin zinc binding moiety. Crystal structures of inhibitors bound to TACE revealed monodentate coordination of the hydantoin to the zinc. SAR, X-ray, and modeling designs are described. To our knowledge, these are the first reported X-ray structures of TACE with a hydantoin zinc ligand.

    Organizational Affiliation: 

    Department of Medicinal Chemistry, Merck Research Laboratories, Kenilworth, NJ 07033, USA. wensheng.yu@spcorp.com




Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
MoleculeChainsSequence LengthOrganismDetails
Disintegrin and metalloproteinase domain-containing protein 17
A, B
270Homo sapiensMutation(s): 3 
Gene Names: ADAM17 (CSVP, TACE)
EC: 3.4.24.86
Find proteins for P78536 (Homo sapiens)
Go to Gene View: ADAM17
Go to UniProtKB:  P78536
Small Molecules
Ligands 4 Unique
IDChainsName / Formula / InChI Key2D Diagram3D Interactions
ZN
Query on ZN
Download SDF File 
Download CCD File 
A, B
ZINC ION
Zn
PTFCDOFLOPIGGS-UHFFFAOYSA-N
 Ligand Interaction
Z94
Query on Z94
Download SDF File 
Download CCD File 
B
N-{4-[(4S)-2,5-dioxoimidazolidin-4-yl]phenyl}acetamide
2-(5-CARBAMIMIDOYL-2-HYDROXY-BENZYLAMINO)-PROPIONIC ACID
C11 H11 N3 O3
GUTQNQMNYWTMBT-VIFPVBQESA-N
 Ligand Interaction
IPA
Query on IPA
Download SDF File 
Download CCD File 
A, B
ISOPROPYL ALCOHOL
2-PROPANOL
C3 H8 O
KFZMGEQAYNKOFK-UHFFFAOYSA-N
 Ligand Interaction
INN
Query on INN
Download SDF File 
Download CCD File 
A
N-{(2R)-2-[2-(hydroxyamino)-2-oxoethyl]-4-methylpentanoyl}-3-methyl-L-valyl-N-(2-aminoethyl)-L-alaninamide
C19 H37 N5 O5
LMIQCBIEAHJAMZ-GZBFAFLISA-N
 Ligand Interaction
Biologically Interesting Molecules 1 Unique
IDChainsNameType/Class2D Diagram3D Interactions
PRD_000919 (INN)
Query on PRD_000919		A3,N(D,L-[2-(HYDROXYAMINO-CARBONYL)METHYL]-4-METHYL PENTANOYL)L-3-(TERT-BUTYL)GLYCYL-L-ALANINEPeptide-like / Enzyme inhibitor

--

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.92 Å
  • R-Value Free: 0.239 
  • R-Value Work: 0.212 
  • Space Group: P 21 21 21
Unit Cell:
Length (Å)Angle (°)
a = 74.198α = 90.00
b = 75.512β = 90.00
c = 102.724γ = 90.00
Software Package:
Software NamePurpose
AMoREphasing
HKL-2000data scaling
BUSTERrefinement
CrystalCleardata collection
HKL-2000data reduction

Structure Validation

View Full Validation Report or Ramachandran Plots


View more in-depth experimental data

Entry History 

Deposition Data

  • Deposited Date: 2009-12-10 
  • Released Date: 2010-03-02 
  • Deposition Author(s): Orth, P.

Revision History 

  • Version 1.0: 2010-03-02
    Type: Initial release
  • Version 1.1: 2011-07-13
    Type: Version format compliance
  • Version 1.2: 2012-12-12
    Type: Other